Authors:
Goldberg, L
Clemenger, M
Azadian, B
Brown, EA
Citation: L. Goldberg et al., Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen, AM J KIDNEY, 37(1), 2001, pp. 49-55
Citation: A. Gaw et al., Analytical performance of the Genzyme LipoPro (TM) Lp(a) kit for plasma lipoprotein(a)-cholesterol assay, BR J BIOMED, 57(1), 2000, pp. 13-18
Citation: Gj. Holmes et al., What's a picture worth? The use of modern telecommunications in diagnosingplant diseases, PLANT DIS, 84(12), 2000, pp. 1256-1265
Citation: A. Gaw et al., Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the Westof Scotland Coronary Prevention Study, ATHEROSCLER, 148(1), 2000, pp. 95-100
Citation: A. Gaw et al., Use of the West of Scotland Coronary Prevention Study bio-bank to provide new insights into the control of plasma lipoprotein(a) concentrations, BIOCH SOC T, 27(4), 1999, pp. 459-463
Authors:
Grossman, F
Potter, WZ
Brown, EA
Maislin, G
Citation: F. Grossman et al., A double-blind study comparing idazoxan and bupropion in bipolar depressedpatients, J AFFECT D, 56(2-3), 1999, pp. 237-243
Citation: A. Gaw et al., Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort, ATHEROSCLER, 143(2), 1999, pp. 445-450
Citation: A. Gaw et al., Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations - Evidence for a threshold effect, ART THROM V, 18(12), 1998, pp. 1870-1876